Generic Drug Prices Are Dropping, but Who Is This Really Benefiting?
It seems that overall drug spending is still on the rise because of the skyrocketing price of new, brand-name drugs.
Big Pharma
Corporate Incentives Make Insurers Favor Pushing Brand-Name Drugs Over Cheaper Generics
Out of public view, corporations are cutting deals that give consumers little choice but to buy brand-name drugs—and sometimes pay more at the pharmacy counter than they would for generics.
Behind Pharmaceutical Companies' Money-Back Guarantees
Drugmakers are increasingly agreeing to refund money if patients don't respond to medications as expected.
The Making of a $455 Million Specialty Pill
The pharmaceutical world is rife with rebates and side deals—all designed to elbow ahead of the competition. But apparently the price of convenience comes at a steep mark-up.
FDA Asks Drug Company to Stop Selling Easy-to-Abuse Painkiller
Endo Pharmaceuticals appears to be preparing its opposition to the FDA's request.
Americans Take Tons of Opioids
The ad was for a drug that targeted constipation in just the kind of patient some say should never have been prescribed opioids in the first place.
Curbing the Opioid Epidemic in Massachusetts
A handful of insurance companies have begun programs that connect their members with social workers.
The Filmmaker Taking on Prescription Drugs
The director of a new documentary about America's prescription drug epidemic talks Big Pharma and opens up about personal struggles with pill addiction.
Biotech Leaders Say Quit Whining About Drug Prices
But the people won't, as the push for pharma reform mounts.
We Know What's in Your Medicine Cabinet
Even our most personal health conditions are part of a vast but hidden market for our medical data. Don't we deserve to know about it?
Who's Reading Your Medical Data?
An early look at a Pacific Standard story that's currently only available to subscribers.
Big Pharma Is Keeping Us From Developing Low-Cost Cancer Treatments
Big Pharma’s focus on blockbuster cancer drugs squeezes out research into potential treatments that are more affordable. Says one researcher: "What is scientific and sexy is driven by what can be monetized."
Psychiatry's Contested Bible: How the New DSM Treats Addiction
The 1,000-page psychiatrists' Big Book will redefine addiction. Critics are already demanding a boycott.